News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all NewsPortfolio Company News
2009 News Archive
Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical
Trial to Evaluate Safety of CCL2-LPM for Inflammatory Kidney Disease
April 16, 2009


